CUSIP: 29428V104
Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
93,676,680
-
Share change
-
-1,427,379
-
Total reported value
-
$479,803,021
-
Put/Call ratio
-
161%
-
Price per share
-
$5.12
-
Number of holders
-
113
-
Value change
-
-$19,984,727
-
Number of buys
-
45
-
Number of sells
-
57
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2021
-
Previous quarter:
Q2 2021
Recent filing periods for CUSIP 29428V104:
Institutional Holders of EPIZYME INC - COM (EPZM) as of Q3 2021
As of 30 Sep 2021,
EPIZYME INC - COM (EPZM) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
93,676,680 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, RP Management, LLC, VANGUARD GROUP INC, BlackRock Inc., Redmile Group, LLC, Palo Alto Investors LP, STATE STREET CORP, BioImpact Capital LLC, KPCB XIII Associates, LLC, and Rock Springs Capital Management LP.
This page lists
113
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.